Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Open Label Evaluation of Nitazoxanide for the Treatment of Cryptosporidiosis in AIDS Patients

NCT00002444 is registered in ClinicalTrials.gov with Unimed Pharmaceuticals as lead sponsor.

NCT NCT00002444
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00002444 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Open Label Evaluation of Nitazoxanide for the Treatment of Cryptosporidiosis in AIDS Patients
Lead sponsor
Unimed Pharmaceuticals
Phase
Phase 1
Overall status
Completed
Start date
October 31, 1995
Completion date
February 29, 1996
Enrollment
28
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections